1.
Alwazzan A, Badeghiesh A, Almansouri M, Mirdad D, Amjad R, Jastaniah Z, et al. Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction. World J Oncol [Internet]. 2026 Jul. 24 [cited 2026 Jul. 24];. Available from: https://wjon.elmerpub.com/wjon/article/view/2800